Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dengue Hemorrhagic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02948933
What this trial is testing

Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 30,000
Not applicableStudy completedNCT07205848
What this trial is testing

Evaluating Public Awareness and Preventive Actions for Dengue Fever in Sudan Amidst Ongoing Crises

Who this might be right for
Dengue Hemorrhagic FeverAwareness
Research and Publication office 164
Large-scale testing (Phase 3)Looking for participantsNCT06747130
What this trial is testing

Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients

Who this might be right for
DengueMontelukastTransaminases
Phramongkutklao College of Medicine and Hospital 82
Not applicableUnknownNCT05919277
What this trial is testing

A Dengue Sero-prevalence Study in the Metropolitan Area of Buenos Aires

Who this might be right for
DengueFlavivirus Infections
Fundacion GESICA 1,487
Not applicableEnded earlyNCT01751139
What this trial is testing

An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil

Who this might be right for
Dengue
GlaxoSmithKline 3,300
Large-scale testing (Phase 3)Study completedNCT02993757
What this trial is testing

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Papillomavirus Disease
Sanofi Pasteur, a Sanofi Company 528
Testing effectiveness (Phase 2)Ended earlyNCT05466240
What this trial is testing

Study of AT-752 in Patients With Dengue Infection

Who this might be right for
Dengue Fever
Atea Pharmaceuticals, Inc. 21
Early research (Phase 1)Study completedNCT02879266
What this trial is testing

Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 28
Not applicableStudy completedNCT01218906
What this trial is testing

Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in Asia

Who this might be right for
Dengue FeverFever
Sanofi 1,500
Early research (Phase 1)Study completedNCT00458120
What this trial is testing

Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus

Who this might be right for
Dengue Hemorrhagic Fever
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT02021968
What this trial is testing

Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)WithdrawnNCT03875560
What this trial is testing

IC14 in Adult Patients With Dengue Fever

Who this might be right for
Dengue Fever
Implicit Bioscience
Not applicableStudy completedNCT04063774
What this trial is testing

Clinical Trial of Diagnostic Tests and Clinical Algorithms for Dengue in Febrile Subjects in Endemic Areas in Colombia

Who this might be right for
Dengue
Lyda Osorio 1,045
Testing effectiveness (Phase 2)Study completedNCT02824198
What this trial is testing

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 118
Testing effectiveness (Phase 2)Study completedNCT02623725
What this trial is testing

Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 251
Early research (Phase 1)Study completedNCT02061358
What this trial is testing

Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects

Who this might be right for
Viral Infection
Emergent BioSolutions 64
Testing effectiveness (Phase 2)Study completedNCT03746015
What this trial is testing

Immunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Naïve and Dengue-Immune Adults

Who this might be right for
Dengue Fever
Takeda 30
Not applicableWithdrawnNCT02134652
What this trial is testing

Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever

Who this might be right for
DengueDisease Progression
University of Massachusetts, Worcester
Not applicableLooking for participantsNCT07007585
What this trial is testing

Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection

Who this might be right for
DengueDengue FeverDengue Fever With Warning Signs
Jose Ivan Rodriguez de Molina Serrano 100
Early research (Phase 1)Ended earlyNCT05366439
What this trial is testing

Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model

Who this might be right for
Dengue
Atea Pharmaceuticals, Inc. 5
Next Page